# Human Albumin Treatment in Adult Septic Shock. A Study Evaluating Immune Response and Organ Failure.

> **NCT05645887** · PHASE2 · WITHDRAWN · sponsor: **Albimmune SL**

## Conditions studied

- Septic Shock

## Interventions

- **DRUG:** Human albumin
- **OTHER:** Saline solution

## Key facts

- **NCT ID:** NCT05645887
- **Lead sponsor:** Albimmune SL
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2024-02
- **Primary completion:** 2024-05-23
- **Final completion:** 2024-05-23
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Internal reorganisations and lack of funding by the sponsor
- **Last updated:** 2024-07-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05645887

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05645887, "Human Albumin Treatment in Adult Septic Shock. A Study Evaluating Immune Response and Organ Failure.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05645887. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*